Analysis – Goldea Capital

McEwen Q2 Results: Net Income of $9.6M ($0.16 per Share), Compared with $3.0M ($0.06 per Share) in Q2 2025; Exploration Results Driving Resource Growth Across All Sites; New Stock Mine in Timmins Nearing Production, with Mine Life Extended

Written by Customer Service on August 6, 2026. Posted in Earnings Releases And Operating Results.

(See Glossary for Defined Terms) TORONTO, Aug. 05, 2026 (GLOBE NEWSWIRE) — McEwen Inc. (NYSE/TSX: MUX) (“McEwen” or the “Company”) today announced its second quarter financial results for the period ended June 30, 2026 (Q2). In addition, the Company is providing an update on its development projects that are forecasted to increase annual production to 250,000 – 300,000 GEOs by 2030 and new exploration results that have intersected very encouraging high grades at the Grey Fox Project, part of the Fox Complex (97.7 gpt gold over 4.4 meters, 64.8 gpt gold over 3.3 meters and 32.5 gpt gold over 5.2 meters) and Tartan Mine Project (17.8 gpt gold over 15.9 meters and 29.1 gpt gold over 10.0 meters). During Q2 the exploration teams at Grey Fox and Tartan have each made new discoveries near existing underground infrastructure, demonstrating...

Braveheart Bio Announces Pricing of Upsized Initial Public Offering

Written by Customer Service on August 6, 2026. Posted in Public Companies.

SAN FRANCISCO, Aug. 05, 2026 (GLOBE NEWSWIRE) — Braveheart Bio, Inc. (Nasdaq: BRVE), a clinical-stage biopharmaceutical company developing next-generation therapeutics for hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases, today announced the pricing of its upsized initial public offering of 21,250,000 shares of its common stock at a public offering price of $18.00 per share. The shares are expected to begin trading on the Nasdaq Global Market on August 6, 2026 under the ticker symbol “BRVE.” The offering is expected to close on August 7, 2026, subject to the satisfaction of customary closing conditions. All shares of common stock are being offered by Braveheart Bio. Braveheart Bio has granted the underwriters a 30-day option to purchase up to an additional 3,187,500 shares of its common stock at the initial...

Fortuna Reports Results for the Second Quarter 2026

Written by Customer Service on August 6, 2026. Posted in Earnings Releases And Operating Results.

(All amounts are expressed in US dollars, tabular amounts in millions, unless otherwise stated) Fortuna Delivers Strong Q2 Results; Positioned To Deliver Our Next Phase of Growth VANCOUVER, British Columbia, Aug. 05, 2026 (GLOBE NEWSWIRE) — Fortuna Mining Corp. (NYSE: FSM | TSX: FVI) (“Fortuna” or the “Company”) today reported its financial and operating results for the second quarter of 2026.(Results from the Company’s San Jose and Yaramoko assets have been excluded from the 2025 comparative figures as they were disposed of during the second quarter of 2025.) Jorge Ganoza, President and CEO of Fortuna, commented, “Fortuna delivered another strong quarter of production, generating $85.7 million of free cash flow from ongoing operations and $200.8 million in adjusted EBITDA, with a robust EBITDA margin of 63%. The second quarter...

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Advances to Expansion Phase in First-Line Hepatocellular Carcinoma Following Positive Efficacy Signals

Written by Customer Service on August 6, 2026. Posted in Public Companies.

NANJING, China, Aug. 05, 2026 (GLOBE NEWSWIRE) — Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,” Stock Code: 9887.HK) today announced that its Phase II clinical study evaluating Opamtistomig (LBL-024), a proprietary PD-L1/4-1BB bispecific antibody, in combination with bevacizumab for the treatment of first-line hepatocellular carcinoma (HCC) has successfully completed the safety run-in phase assessment following expert review and has advanced into the expansion phase. The study is led by Professor Zhou Jian, President of Zhongshan Hospital, Fudan University, and Academician of the Chinese Academy of Sciences. Preliminary clinical data demonstrated that Opamtistomig in combination with bevacizumab has shown encouraging anti-tumor activity and a favorable safety profile in patients with HCC, supporting further...

UPDATE – LifeMD Reports Second Quarter 2026 Results

Written by Customer Service on August 5, 2026. Posted in Earnings Releases And Operating Results.

UPDATE this press release has been updated to remove a duplicate table.Second quarter 2026 revenue of $47.3 million, within the Company’s guidance range of $47 million to $50 million; adjusted EBITDA loss of approximately $3.5 million, improving approximately 21% sequentially. Approximately 95% of all new weight management patients now begin treatment with branded GLP-1 therapies; with the guidance provided today, the Company believes it is effectively at the end of its transition away from compounded GLP-1 medications. Gross margin expanded approximately 280 basis points versus the second quarter of 2025 to approximately 89%, reflecting lower shipping and fulfillment costs and the continued scaling of the Company’s in-house pharmacy. Weight Management Program subscribers grew to approximately 108,000 at quarter end; total active subscribers...

Built for Confidence: The Manufacturing Strength Behind FREELANDER 8

Written by Customer Service on August 5, 2026. Posted in Public Companies.

SHANGHAI, China, Aug. 05, 2026 (GLOBE NEWSWIRE) — As the British Premium Intelligent All-Terrain Brand, FREELANDER is accelerating its global expansion following the start of mass production and preparations for its Middle East debut, long-term competitiveness depends not only on product innovation, but also on manufacturing excellence. Behind FREELANDER 8 stands the Chery Jaguar Land Rover Changshu Manufacturing Base — a facility supported by a total investment of over 3.1 Billion USD, including an additional 440 Million USD investment dedicated for NEV intelligent manufacturing upgrades. As Jaguar Land Rover’s first full-vehicle manufacturing plant outside the UK, the facility combines Jaguar Land Rover’s premium manufacturing heritage with Chery’s advanced NEV technologies, providing the production capability,...

Hudson Technologies Re-Awarded Defense Logistics Agency Contract

Written by Customer Service on August 5, 2026. Posted in Public Companies.

WOODCLIFF LAKE, N.J., Aug. 05, 2026 (GLOBE NEWSWIRE) — Hudson Technologies, Inc. (NASDAQ: HDSN) a leading provider of innovative and sustainable refrigerant products and services to the Heating, Ventilation, Air Conditioning, and Refrigeration industry – and one of the nation’s largest refrigerant reclaimers – announced that it was notified by the United States Defense Logistics Agency (“DLA”) that it has been re-awarded the previously disputed and rescinded Indefinite Delivery Indefinite Quantity (IDIQ) contract with the DLA. The initial term of the agreement runs through August 4, 2031 and is valued at $210 million, with the DLA holding a five-year option to extend the term through July 31, 2036. As previously disclosed, Hudson Technologies was notified in January 2026 that an unsuccessful bidder had filed a bid protest at the...

Trekor Announces $125 Million of Adjusted EBITDA in Second Quarter

Written by Customer Service on August 5, 2026. Posted in Earnings Releases And Operating Results.

Total Operating Costs (C1*) (US$ per pound of copper produced)Total Operating Costs (C1*) (US$ per pound of copper produced)VANCOUVER, British Columbia, Aug. 05, 2026 (GLOBE NEWSWIRE) — Trekor Metals Limited (TSX: TKO; NYSE American: TGB; LSE: TKO) (“Trekor” or the “Company”) reports second quarter 2026 Adjusted EBITDA* of $125 million. Earnings from mining operations before depletion and amortization and non-recurring items* was $154 million. Revenues in the second quarter were $331 million from consolidated sales of 37.5 million pounds of copper and 575 thousand pounds of molybdenum. Second quarter net income was $22 million ($0.06 per share) and Adjusted net income* was $40 million ($0.11 per share). Stuart McDonald, President & CEO of Trekor, commented, “Record copper prices and strong...

Intermountain Power Agency Announces the Issuance of a Request for Proposals for Acquisition of IPP Coal-Fueled Generating Units

Written by Customer Service on August 5, 2026. Posted in Mergers And Acquisitions.

RFP process conducted in cooperation with Utah Energy Council seeks qualified proposals for potential continued use of coal resources South Jordan, Utah, Aug. 05, 2026 (GLOBE NEWSWIRE) — Intermountain Power Agency has issued a Notice of Availability for a Request for Proposals seeking qualified parties interested in the potential acquisition of the coal-fueled generating units and related assets at the Intermountain Power Project near Delta, Utah. The two coal-fueled units ceased operation for IPP in November 2025 following the commercial operation of new advanced-class natural gas generating units constructed as part of the IPP Renewed project. Although the coal units are no longer used to generate electricity for IPP, they are being maintained in operable condition consistent with the requirements of Utah law. The RFP process...

Beyond Meat® Reports Second Quarter 2026 Financial Results

Written by Customer Service on August 5, 2026. Posted in Earnings Releases And Operating Results.

EL SEGUNDO, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) — Beyond Meat, Inc. (NASDAQ: BYND), otherwise known as Beyond The Plant Protein Company™ (the “Company” or “Beyond Meat”), today reported financial results for its second quarter ended June 27, 2026. Second Quarter 2026 Financial Highlights1Net revenues were $68.8 million, a decrease of 8.2% year-over-year. Gross profit was $5.9 million, or gross margin of 8.5%, compared to gross profit of $7.9 million, or gross margin of 10.6%, in the year-ago period.Gross profit and gross margin included $1.6 million in expenses related to the cessation of the Company’s operational activities in China, compared to $1.7 million in the year-ago period.Loss from operations was $30.8 million, or operating margin of -44.8%, compared to loss from operations of $37.5 million, or operating...

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals